Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CBIZ, Inc.CBZ · Entity 4243 | Director | May 18, 2020 | May 20, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CBIZ, Inc.
Report date May 18, 2020 · Filed May 20, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,999 |
Reported balance
After 2020-05-18 transaction · row 1
1 source rowRow 1 · 2020-05-18 · Sale · Disposed 6,107 · Balance 9,999 |
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Teligent, Inc.
Report date August 19, 2020 · Filed September 16, 2020
Jointly reported with LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP, LIFE SCIENCES OPPORTUNITIES FUND II LP, SIGNET HEALTHCARE PARTNERS, LLC, GALE JAMES C, SANDERS DON A, MORRIS BEN T
Section 16 reporting ended · disclosed 2020-09-16. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 761,680 |
Reported balance
After 2020-08-19 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2020-08-19 · Sale · Disposed 74,020 · Balance 761,680 F1: These securities are owned directly by Life Sciences Opportunities Fund (Institutional) II, L.P. and indirectly by the Signet Healthcare Partners, LLC ("General Partner"), the general partner of Life Sciences Opportunities Fund II, L.P., James C. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW Investments I, LLC ("SMW") and Don A. Sanders, Ben T. Morris, and Donald V. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. |
| Common StockSEC Table I · non-derivative | Direct | 136,237 |
Reported balance
After 2020-08-19 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2020-08-19 · Sale · Disposed 13,251 · Balance 136,237 F2: These securities are owned directly by Life Sciences Opportunities Fund II, L.P. and indirectly by the General Partner, Mr. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW, and Mr. Sanders, Mr. Morris, and Mr. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. |
| Common StockSEC Table I · non-derivative | Direct | 658,718 |
Reported balance
After 2020-08-21 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2020-08-21 · Sale · Disposed 102,962 · Balance 658,718 F1: These securities are owned directly by Life Sciences Opportunities Fund (Institutional) II, L.P. and indirectly by the Signet Healthcare Partners, LLC ("General Partner"), the general partner of Life Sciences Opportunities Fund II, L.P., James C. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW Investments I, LLC ("SMW") and Don A. Sanders, Ben T. Morris, and Donald V. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. |
| Common StockSEC Table I · non-derivative | Direct | 117,805 |
Reported balance
After 2020-08-21 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2020-08-21 · Sale · Disposed 18,432 · Balance 117,805 F2: These securities are owned directly by Life Sciences Opportunities Fund II, L.P. and indirectly by the General Partner, Mr. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW, and Mr. Sanders, Mr. Morris, and Mr. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. |
| Common StockSEC Table I · non-derivative | Direct | 573,902 |
Reported balance
After 2020-08-25 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2020-08-25 · Sale · Disposed 84,816 · Balance 573,902 F1: These securities are owned directly by Life Sciences Opportunities Fund (Institutional) II, L.P. and indirectly by the Signet Healthcare Partners, LLC ("General Partner"), the general partner of Life Sciences Opportunities Fund II, L.P., James C. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW Investments I, LLC ("SMW") and Don A. Sanders, Ben T. Morris, and Donald V. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. |
| Common StockSEC Table I · non-derivative | Direct | 102,621 |
Reported balance
After 2020-08-25 transaction · row 6
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 6 · 2020-08-25 · Sale · Disposed 15,184 · Balance 102,621 F2: These securities are owned directly by Life Sciences Opportunities Fund II, L.P. and indirectly by the General Partner, Mr. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW, and Mr. Sanders, Mr. Morris, and Mr. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. |
| Common StockSEC Table I · non-derivative | Direct | 98,390 |
Reported balance
After 2020-08-26 transaction · row 7
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 7 · 2020-08-26 · Sale · Disposed 475,512 · Balance 98,390 F1: These securities are owned directly by Life Sciences Opportunities Fund (Institutional) II, L.P. and indirectly by the Signet Healthcare Partners, LLC ("General Partner"), the general partner of Life Sciences Opportunities Fund II, L.P., James C. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW Investments I, LLC ("SMW") and Don A. Sanders, Ben T. Morris, and Donald V. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. |
| Common StockSEC Table I · non-derivative | Direct | 17,515 |
Reported balance
After 2020-08-26 transaction · row 8
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 8 · 2020-08-26 · Sale · Disposed 85,106 · Balance 17,515 F2: These securities are owned directly by Life Sciences Opportunities Fund II, L.P. and indirectly by the General Partner, Mr. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW, and Mr. Sanders, Mr. Morris, and Mr. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities are owned directly by Life Sciences Opportunities Fund (Institutional) II, L.P. and indirectly by the Signet Healthcare Partners, LLC ("General Partner"), the general partner of Life Sciences Opportunities Fund II, L.P., James C. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW Investments I, LLC ("SMW") and Don A. Sanders, Ben T. Morris, and Donald V. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any.
F2: These securities are owned directly by Life Sciences Opportunities Fund II, L.P. and indirectly by the General Partner, Mr. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW, and Mr. Sanders, Mr. Morris, and Mr. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 26, 2020 Filed Sep 16, 2020 20:44 UTC | Teligent, Inc. TLGT · Entity 134764 | SaleCommon Stock | 85,106 | $1.25 | $106,195.27 |
DisclosureSEC source: 0001213900-20-027008 · ownership.xml · nonDerivative · entry 8 LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP · CIK 0001269417 · Director · 10% owner LIFE SCIENCES OPPORTUNITIES FUND II LP · CIK 0001269415 · 10% owner SIGNET HEALTHCARE PARTNERS, LLC · CIK 0001280952 · 10% owner GALE JAMES C · CIK 0001184312 · Director · 10% owner SANDERS DON A · CIK 0000904778 · 10% owner MORRIS BEN T · CIK 0001214494 · 10% owner WEIR DONALD V · CIK 0001006309 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,515 F2 · ownership.direct: These securities are owned directly by Life Sciences Opportunities Fund II, L.P. and indirectly by the General Partner, Mr. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW, and Mr. Sanders, Mr. Morris, and Mr. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. Read SEC document |
| August 26, 2020 Filed Sep 16, 2020 20:44 UTC | Teligent, Inc. TLGT · Entity 134764 | SaleCommon Stock | 475,512 | $1.24 | $591,299.17 |
DisclosureSEC source: 0001213900-20-027008 · ownership.xml · nonDerivative · entry 7 LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP · CIK 0001269417 · Director · 10% owner LIFE SCIENCES OPPORTUNITIES FUND II LP · CIK 0001269415 · 10% owner SIGNET HEALTHCARE PARTNERS, LLC · CIK 0001280952 · 10% owner GALE JAMES C · CIK 0001184312 · Director · 10% owner SANDERS DON A · CIK 0000904778 · 10% owner MORRIS BEN T · CIK 0001214494 · 10% owner WEIR DONALD V · CIK 0001006309 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,390 F1 · ownership.direct: These securities are owned directly by Life Sciences Opportunities Fund (Institutional) II, L.P. and indirectly by the Signet Healthcare Partners, LLC ("General Partner"), the general partner of Life Sciences Opportunities Fund II, L.P., James C. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW Investments I, LLC ("SMW") and Don A. Sanders, Ben T. Morris, and Donald V. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. Read SEC document |
| August 25, 2020 Filed Sep 16, 2020 20:44 UTC | Teligent, Inc. TLGT · Entity 134764 | SaleCommon Stock | 15,184 | $1.13 | $17,106.29 |
DisclosureSEC source: 0001213900-20-027008 · ownership.xml · nonDerivative · entry 6 LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP · CIK 0001269417 · Director · 10% owner LIFE SCIENCES OPPORTUNITIES FUND II LP · CIK 0001269415 · 10% owner SIGNET HEALTHCARE PARTNERS, LLC · CIK 0001280952 · 10% owner GALE JAMES C · CIK 0001184312 · Director · 10% owner SANDERS DON A · CIK 0000904778 · 10% owner MORRIS BEN T · CIK 0001214494 · 10% owner WEIR DONALD V · CIK 0001006309 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,621 F2 · ownership.direct: These securities are owned directly by Life Sciences Opportunities Fund II, L.P. and indirectly by the General Partner, Mr. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW, and Mr. Sanders, Mr. Morris, and Mr. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. Read SEC document |
| August 25, 2020 Filed Sep 16, 2020 20:44 UTC | Teligent, Inc. TLGT · Entity 134764 | SaleCommon Stock | 84,816 | $1.13 | $96,147.42 |
DisclosureSEC source: 0001213900-20-027008 · ownership.xml · nonDerivative · entry 5 LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP · CIK 0001269417 · Director · 10% owner LIFE SCIENCES OPPORTUNITIES FUND II LP · CIK 0001269415 · 10% owner SIGNET HEALTHCARE PARTNERS, LLC · CIK 0001280952 · 10% owner GALE JAMES C · CIK 0001184312 · Director · 10% owner SANDERS DON A · CIK 0000904778 · 10% owner MORRIS BEN T · CIK 0001214494 · 10% owner WEIR DONALD V · CIK 0001006309 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 573,902 F1 · ownership.direct: These securities are owned directly by Life Sciences Opportunities Fund (Institutional) II, L.P. and indirectly by the Signet Healthcare Partners, LLC ("General Partner"), the general partner of Life Sciences Opportunities Fund II, L.P., James C. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW Investments I, LLC ("SMW") and Don A. Sanders, Ben T. Morris, and Donald V. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. Read SEC document |
| August 21, 2020 Filed Sep 16, 2020 20:44 UTC | Teligent, Inc. TLGT · Entity 134764 | SaleCommon Stock | 18,432 | $1.66 | $30,539.98 |
DisclosureSEC source: 0001213900-20-027008 · ownership.xml · nonDerivative · entry 4 LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP · CIK 0001269417 · Director · 10% owner LIFE SCIENCES OPPORTUNITIES FUND II LP · CIK 0001269415 · 10% owner SIGNET HEALTHCARE PARTNERS, LLC · CIK 0001280952 · 10% owner GALE JAMES C · CIK 0001184312 · Director · 10% owner SANDERS DON A · CIK 0000904778 · 10% owner MORRIS BEN T · CIK 0001214494 · 10% owner WEIR DONALD V · CIK 0001006309 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,805 F2 · ownership.direct: These securities are owned directly by Life Sciences Opportunities Fund II, L.P. and indirectly by the General Partner, Mr. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW, and Mr. Sanders, Mr. Morris, and Mr. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. Read SEC document |
| August 21, 2020 Filed Sep 16, 2020 20:44 UTC | Teligent, Inc. TLGT · Entity 134764 | SaleCommon Stock | 102,962 | $1.66 | $171,071.36 |
DisclosureSEC source: 0001213900-20-027008 · ownership.xml · nonDerivative · entry 3 LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP · CIK 0001269417 · Director · 10% owner LIFE SCIENCES OPPORTUNITIES FUND II LP · CIK 0001269415 · 10% owner SIGNET HEALTHCARE PARTNERS, LLC · CIK 0001280952 · 10% owner GALE JAMES C · CIK 0001184312 · Director · 10% owner SANDERS DON A · CIK 0000904778 · 10% owner MORRIS BEN T · CIK 0001214494 · 10% owner WEIR DONALD V · CIK 0001006309 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 658,718 F1 · ownership.direct: These securities are owned directly by Life Sciences Opportunities Fund (Institutional) II, L.P. and indirectly by the Signet Healthcare Partners, LLC ("General Partner"), the general partner of Life Sciences Opportunities Fund II, L.P., James C. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW Investments I, LLC ("SMW") and Don A. Sanders, Ben T. Morris, and Donald V. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. Read SEC document |
| August 19, 2020 Filed Sep 16, 2020 20:44 UTC | Teligent, Inc. TLGT · Entity 134764 | SaleCommon Stock | 13,251 | $2.25 | $29,760.42 |
DisclosureSEC source: 0001213900-20-027008 · ownership.xml · nonDerivative · entry 2 LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP · CIK 0001269417 · Director · 10% owner LIFE SCIENCES OPPORTUNITIES FUND II LP · CIK 0001269415 · 10% owner SIGNET HEALTHCARE PARTNERS, LLC · CIK 0001280952 · 10% owner GALE JAMES C · CIK 0001184312 · Director · 10% owner SANDERS DON A · CIK 0000904778 · 10% owner MORRIS BEN T · CIK 0001214494 · 10% owner WEIR DONALD V · CIK 0001006309 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,237 F2 · ownership.direct: These securities are owned directly by Life Sciences Opportunities Fund II, L.P. and indirectly by the General Partner, Mr. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW, and Mr. Sanders, Mr. Morris, and Mr. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. Read SEC document |
| August 19, 2020 Filed Sep 16, 2020 20:44 UTC | Teligent, Inc. TLGT · Entity 134764 | SaleCommon Stock | 74,020 | $2.26 | $167,026.13 |
DisclosureSEC source: 0001213900-20-027008 · ownership.xml · nonDerivative · entry 1 LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP · CIK 0001269417 · Director · 10% owner LIFE SCIENCES OPPORTUNITIES FUND II LP · CIK 0001269415 · 10% owner SIGNET HEALTHCARE PARTNERS, LLC · CIK 0001280952 · 10% owner GALE JAMES C · CIK 0001184312 · Director · 10% owner SANDERS DON A · CIK 0000904778 · 10% owner MORRIS BEN T · CIK 0001214494 · 10% owner WEIR DONALD V · CIK 0001006309 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 761,680 F1 · ownership.direct: These securities are owned directly by Life Sciences Opportunities Fund (Institutional) II, L.P. and indirectly by the Signet Healthcare Partners, LLC ("General Partner"), the general partner of Life Sciences Opportunities Fund II, L.P., James C. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW Investments I, LLC ("SMW") and Don A. Sanders, Ben T. Morris, and Donald V. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. Read SEC document |
| May 18, 2020 Filed May 20, 2020 20:13 UTC | CBIZ, Inc. CBZ · Entity 4243 | SaleCommon Stock | 6,107 | $21.97 | $134,161.02 |
DisclosureSEC source: 0001127602-20-017346 · form4.xml · nonDerivative · entry 1 WEIR DONALD V · CIK 0001006309 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,999 Read SEC document |
| May 07, 2020 Filed May 11, 2020 20:06 UTC | CBIZ, Inc. CBZ · Entity 4243 | SaleCommon Stock | 6,956 | $21.79 | $151,574.72 |
DisclosureSEC source: 0001127602-20-016067 · form4.xml · nonDerivative · entry 1 WEIR DONALD V · CIK 0001006309 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,106 Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 19:49 UTC | CBIZ, Inc. CBZ · Entity 4243 | GrantCommon Stock | 5,000 | $25.89 | $129,436.00 |
DisclosureSEC source: 0001127602-20-008518 · form4.xml · nonDerivative · entry 1 WEIR DONALD V · CIK 0001006309 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,062 F1 · security: Restricted Stock vesting 50% in each of the two years following date of award. Annual non-employee Director compensation grant awarded at second quarter Board meeting. F2 · security: Restricted Stock vesting 50% in each of the two years following date of award. Annual non-employee Director compensation grant awarded at first quarter Board meeting Read SEC document |
| May 08, 2019 Filed May 10, 2019 22:36 UTC | CBIZ, Inc. CBZ · Entity 4243 | GrantCommon Stock | 6,107 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-018205 · form4.xml · nonDerivative · entry 1 WEIR DONALD V · CIK 0001006309 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,062 F1 · security: Restricted Stock vesting 50% in each of the two years following date of award. Annual non-employee Director compensation grant awarded at second quarter Board meeting. Read SEC document |
| August 31, 2018 Filed Sep 5, 2018 20:23 UTC | CBIZ, Inc. CBZ · Entity 4243 | SaleCommon Stock | 10,000 | $23.77 | $237,747.00 |
DisclosureSEC source: 0001127602-18-026794 · form4.xml · nonDerivative · entry 1 WEIR DONALD V · CIK 0001006309 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,955 F1 · security: Restricted Stock vesting 50% in each of the two years following date of award. Annual non-employee Director compensation grant awarded at first quarter Board meeting. F2 · security: Restricted Stock vesting 50% in each of the two years following date of award. Annual non-employee Director compensation grant awarded at first quarter Board meeting Read SEC document |
| May 24, 2018 Filed May 29, 2018 20:53 UTC | CBIZ, Inc. CBZ · Entity 4243 | SaleCommon stock | 10,000 | $20.31 | $203,071.00 |
DisclosureSEC source: 0001225208-18-009912 · doc4.xml · nonDerivative · entry 1 WEIR DONALD V · CIK 0001006309 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,955 Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 18:32 UTC | CBIZ, Inc. CBZ · Entity 4243 | GrantCommon stock | 6,192 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002385 · doc4.xml · nonDerivative · entry 1 WEIR DONALD V · CIK 0001006309 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,955 F1 · security: Restricted Stock vesting 50% in each of the two years following date of award. Annual non-employee Director compensation grant awarded at first quarter Board meeting Read SEC document |
| May 17, 2017 Filed May 19, 2017 20:51 UTC | CBIZ, Inc. CBZ · Entity 4243 | SaleCommon stock | 10,000 | $15.22 | $152,240.00 |
DisclosureSEC source: 0001225208-17-010131 · doc4.xml · nonDerivative · entry 1 WEIR DONALD V · CIK 0001006309 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,763 Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 22:11 UTC | CBIZ, Inc. CBZ · Entity 4243 | GrantCommon stock | 7,783 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-002800 · doc4.xml · nonDerivative · entry 1 WEIR DONALD V · CIK 0001006309 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,763 F1 · security: Restricted Stock vesting 50% in each of the two years following date of award. Annual non-employee Director compensation grant awarded at first quarter Board meeting Read SEC document |
| December 13, 2016 Filed Dec 15, 2016 21:38 UTC | CBIZ, Inc. CBZ · Entity 4243 | SaleCommon stock | 20,000 | $13.49 | $269,800.00 |
DisclosureSEC source: 0001225208-16-043329 · doc4.xml · nonDerivative · entry 1 WEIR DONALD V · CIK 0001006309 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,980 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.